Insulin resistance in limb and trunk partial lipodystrophy (type 2 Kobberling-Dunnigan syndrome)

Metabolism: Clinical and Experimental

Volumn 46, Issue 2, 1997, Pages 159-163

  Ursich, Mileni J M ^a   Fukui, Rosa T ^a   Galvão, Maria S A ^a   Marcondes, Jose A M ^a   Santomauro, Ana T M G ^a   Silva, Maria E R ^a   Rocha, Dalva M ^a   Wajchenberg, Bernardo L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ACANTHOSIS NIGRICANS; ADIPOCYTE; ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HIRSUTISM; HUMAN; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPODYSTROPHY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYNDROME DELINEATION;

EID: 0031055078     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90295-X     Document Type: Article

References (30)

1. Köbberling J, Dunnigan MG: Familial partial lipodystrophy: Two types of an X-linked dominant syndrome, lethal in the homozygous state. J Med Genet 23:120-127, 1986
2. Oseid S, Beck-Nielsen H, Pedersen P, et al: Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med 296:248-250, 1977
3. Kodama S, Kasuga M, Seki A, et al: Congenital generalized lipodystrophy with insulin-resistant diabetes. Eur J Pediatr 127:111-119, 1978
4. Wachslicht-Rodbard H, Muggeo M, Kahn R, et al: Heterogeneity of the insulin-receptor interaction in lipoatrophic diabetes. J Clin Endocrinol Metab 52:416-425, 1981
5. Dörfler H, Wieczorek A, Wolfram G, et al: Binding of insulin to fibroblasts in lipoatrophic diabetes. Res Exp Med 170:161-168, 1977
6. Rosenbloom AL, Goldstein S, Yip CC: Normal insulin binding to cultured fibroblasts from patients with lipoatrophic diabetes. J Clin Endocrinol Metab 44:803-806, 1977
7. Howard BV, Mott DM, Fields RM, et al: Cell culture studies of a patient with congenital lipoatrophic diabetes - Normal insulin binding with alterations in intracellular glucose metabolism and insulin action. Metabolism 30:845-852, 1981
8. Martins MCN, Silva ME, Pupo AA: Micro ITT to evaluate tissue insulin sensitivity. Arq Bras Endocrinol Metab 31:35-45, 1987
9. DeFronzo RA, Tobin J, Andres R: Glucose clamp technique, a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
10. Fulcher GR, Walker M, Catalano C, et al: Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41:542-544, 1992
11. Wasko ME. Rice EW: Determination of glucose by an improved enzymatic procedure. Clin Chem 7:1005-1066, 1961
12. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732-738, 1971
13. Sield J, Hagle EO, Ziegenhorm J, et al: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 26:1075-1080, 1983
14. McGowan MW, Artiss JD, Strandberg DR, et al: A peroxidasecoupled method for the calorimetric determination of serum triglycerides. Clin Chem 29:538-542, 1983
15. Abraham F: Radioimraunoassay of steroid in biological material. Acta Endocrinol (Copenh) 75:1-42, 1974 (suppl 183)
16. Chromy V, Gergel J, Vozniceck J, et al: Assay of serum free fatty acids by extraction-photometric procedure. Clin Chim Acta 80:327-332, 1977
17. Demacker PNM, Hijmans AGM, Jansen AP: Enzymic and chemical-extraction determinations of free fatty acids in serum compared with FFA methods. Clin Chem 28:1765-1768, 1982
18. Freychet P, Roth J, Neville DM Jr: Mono-iodoinsulin: Demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun 43:400-408, 1991
19. Rodbell M: Metabolism of isolated rat cells. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380, 1964
20. Ursich MJM, Fukui RT, Rocha DM, et al: Metabolic derangements in excessive insulin and sulfonylurea therapy. Horm Metab Res 25:457-461, 1993
21. Flier JS, Eastman RC, Minaker KL, et al: Acanthosis nigricans in obese women with hyperandrogenism: Characterization of an insulin-resistant state distinct from the type B and A syndromes. Diabetes 34:105-107, 1985
22. Stuart CA, Peters EJ, Prince MJ, et al: Insulin resistance with acanthosis nigricans: The roles of obesity and androgen excess. Metabolism 35:197-205, 1986
23. Dunnigan MG, Cochrane MA, Kelly A, et al: Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q J Med 169:33-48, 1974
24. Köbberling J, Willms B, Kattermann R, et al: Lipodystrophy of the extremities. A dominant inherited syndrome associated with lipoatrophic diabetes. Hum Genet 29:111-120, 1975
25. Bernstein RS, Pierson RN III, Ryan SF, et al: Adipose cell morphology and control of lipolysis in a patient with partial lipodystrophy. Metabolism 28:519-526, 1979
26. Copeland KC, Nair KS, Kaplowitz PB, et al: Discordant metabolic actions of insulin in extreme lipodystrophy of childhood. J Clin Endocrinol Metab 77:1240-1245, 1993
27. Robbins DC, Horton ES, Tiulp O, et al: Familial partial lipodystrophy: Complications of obesity in the non-obese? Metabolism 31:445-452, 1982
28. Davidson MB, Young RT: Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities. Diabetologia 11:561-568, 1975
29. Boucher BJ, Cohen RD, Frankel RJ, et al: Partial and total lipodystrophy: Changes in circulating sugar, free fatty acids, insulin and growth hormone following the administration of glucose and of insulin. Clin Endocrinol (Oxf) 2:111-126, 1973
30. Groop LC, Saloranta C, Shank M, et al: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Invest 72:96-107, 1991